Cart
sales@molnova.com
Ginsenoside Z-R1
CAS No. 80930-74-1
Ginsenoside Z-R1( —— )
Catalog No. M19831 CAS No. 80930-74-1
Zingibroside R1 has anti-HIV-1 activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 225 | In Stock |
|
| 10MG | 331 | In Stock |
|
| 25MG | 561 | In Stock |
|
| 50MG | 798 | In Stock |
|
| 100MG | 1098 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGinsenoside Z-R1
-
NoteResearch use only, not for human use.
-
Brief DescriptionZingibroside R1 has anti-HIV-1 activity.
-
DescriptionZingibroside R1 has anti-HIV-1 activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80930-74-1
-
Formula Weight794.97
-
Molecular FormulaC42H66O14
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1(C)CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O)[C@H](O)[C@H]6O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(O)=O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]2C1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yoshizaki K Devkota H P Fujino H et al. Saponins Composition of Rhizomes Taproots and Lateral Roots of Satsuma-ninjin (Panax japonicus)[J]. Chemical and Pharmaceutical Bulletin 2013 61(3):344-350.
molnova catalog
related products
-
Peptide T
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action.
-
1E7-03
1E7-03 is a small molecule targeting the RVxF interacting site on PP1, inhibits HIV-1, Ebolavirus (EBOV), and Venezuelan equine encephalitis virus (VEEV, EC50=0.6 uM).
-
Lersivirine(UK 45306...
Lersivirine(UK 453061) is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) under development for HIV infection therapy.?
